5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile
C25H28N4O3 — CID 123475872
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile
5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile (PubChem CID 123475872) has the molecular formula C25H28N4O3 and a molecular weight of 432.52 g/mol. Its IUPAC name is 5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile.
Molecular Properties
| Compound Name | 5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile |
|---|---|
| PubChem CID | 123475872 |
| Molecular Formula | C25H28N4O3 |
| Molecular Weight | 432.52 g/mol |
| Exact Mass | 432.22 |
| IUPAC Name | 5-[5-[3-[2-hydroxyethyl(methyl)amino]prop-1-enyl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-2-(oxan-4-yloxy)benzonitrile |
| SMILES | CN(CC=Cc1cnc2[nH]cc(-c3ccc(OC4CCOCC4)c(C#N)c3)c2c1)CCO |
| InChI | InChI=1S/C25H28N4O3/c1-29(9-10-30)8-2-3-18-13-22-23(17-28-25(22)27-16-18)19-4-5-24(20(14-19)15-26)32-21-6-11-31-12-7-21/h2-5,13-14,16-17,21,30H,6-12H2,1H3,(H,27,28) |
| InChIKey | DPVXEDFGCAZFEV-UHFFFAOYSA-N |
| XLogP | 3.60 |
| TPSA | 94.40 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.52 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123475872 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.